Genetic Clue to Treating Irritable Bowel Syndrome

Genetics researchers in the UK have identified a genetic variant that doubles an individual’s risk of developing ulcerative colitis, one of the subtypes of a chronic disorder known as Inflammatory Bowel Disease (IBD). The investigators, from the Wellcome Trust Sanger Institute and other centers, also uncovered a further 25 novel genetic associations to IBD risk.… Continue reading Genetic Clue to Treating Irritable Bowel Syndrome

Are We Close to a Better Treatment for Ulcerative Colitis?

Experts are optimistic about a one-step ulcerative colitis treatment that uses an oral drug consisting of microparticles and natural herbal molecules that target the colon. The treatment was developed by researchers from the Institute for Biomedical Sciences at Georgia State University and Southwest University in China. The findings, published in the journal Colloids and Surfaces… Continue reading Are We Close to a Better Treatment for Ulcerative Colitis?

Promising Treatment for Irritable Bowel Syndrome

Pinaverium offers quick and effective relief of irritable bowel syndrome (IBS) symptoms, according to clinical trial results published in June 2015 in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. A release from the association notes that pinaverium bromide (pinaverium), an antispasmodic, is used widely in many countries around… Continue reading Promising Treatment for Irritable Bowel Syndrome

Update on Irritable Bowel Syndrome Treatments

Irritable bowel syndrome (IBS) is an often misunderstood and underdiagnosed condition that affects about 15.3 million people in the United States. No one remedy works for all patients, so there’s a great medical need to develop new therapies for IBS, says Andrew Mulberg, M.D., a gastroenterologist with the Food and Drug Administration (FDA). That’s why… Continue reading Update on Irritable Bowel Syndrome Treatments